ChartRow logo
Data provided bySource: Twelve Data
IX
$33.29-1.01%
as of close, Nov 17, 2026
☾ AH $33.29 -1.01%
PeersMUFGLYGTAKNWGBCSFRHC
Share this page

IX financial statements

The full income statement, balance sheet, and cash-flow statement for ORIX Corporation American Depositary Shares (IX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +0.4%10Y CAGR +1.1%
$22B FY26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

No quarters filed for this figure.

Gross profit

5Y CAGR +0.8%5Y CAGR +0.8%
— FY26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

No quarters filed for this figure.

Operating income

5Y CAGR +4.3%10Y CAGR +2.3%
$3B FY26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

No quarters filed for this figure.

Net income

5Y CAGR +10.3%10Y CAGR +3.2%
$3B FY26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

No quarters filed for this figure.

EPS (diluted)

5Y CAGR +12.5%10Y CAGR +4.8%
$2.64 FY26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

No quarters filed for this figure.

Operating cash flow

5Y CAGR −2.7%10Y CAGR +7.8%
$9.1B FY26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

No quarters filed for this figure.

Capital expenditure

5Y CAGR +3.7%10Y CAGR −4.2%
$496.2M FY26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

No quarters filed for this figure.

Free cash flow

5Y CAGR −3.0%10Y CAGR +9.4%
$8.6B FY26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

No quarters filed for this figure.

Shares (diluted)

5Y −9.6%10Y −14.5%
1.1B FY26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

No quarters filed for this figure.

Dividend per share

5Y CAGR +6.9%10Y CAGR +7.6%
$1.00 FY26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

No quarters filed for this figure.

Every IX chart on Trends →

Shares outstanding (point-in-time)

2018-03 1.32B2019-03 1.32B2020-03 1.32B2021-03 1.29B2022-03 1.20B2023-03 1.18B2024-03 1.16B2025-03 1.16B2026-03 1.12B-15.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2026FY2025FY2024FY2023FY2022
Income Statementas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
22.0B+16.8%18.9B-3.1%19.4B-1.1%19.7B-11.9%22.3B+3.2%
Lease income4.24B+3.5%4.09B+10.7%3.70B+0.3%3.69B-8.0%4.01B+7.0%
Selling, general & administrative4.70B+11.1%4.24B-2.3%4.34B+5.0%4.13B-11.2%4.65B+8.0%
Amortization of intangibles274M+0.8%271M+0.2%271M+7.2%253M-11.9%287M+5.8%
Provision for credit losses47.7M+37.2%34.7M-76.0%145M+153.0%57.3M+63.4%35.1M-76.8%
Operating income3.02B+38.6%2.18B-12.7%2.49B+0.5%2.48B-4.8%2.61B+6.8%
Interest expense1.28B+15.6%1.11B-14.8%1.30B+38.1%942M+55.2%607M-17.5%
Interest & investment income250M+30.8%191M+5.0%182M+23.8%147M+29.7%113M+1.3%
Equity-method income819M+118.4%375M+47.6%254M+55.8%163M-25.4%219M+4719.1%
Gain (loss) on equity securities1.12B+3776.8%29.0M-92.1%368M+176.2%133M-42.5%232M-70.6%
Pre-tax income4.57B+45.1%3.15B-3.0%3.25B+12.1%2.90B-36.1%4.53B+67.2%
Income tax1.54B+82.4%845M-7.0%908M+29.1%703M-57.6%1.66B+94.0%
2.96B+28.2%2.31B-3.6%2.39B+11.5%2.14B-24.1%2.82B+55.7%
Net income to non-controlling interest73.1M+222930.7%32.8K+100.1%-52.1M-207.1%48.7M-0.1%48.7M+16.7%
Net income to common2.96B+28.2%2.31B-3.6%2.39B+11.5%2.14B-24.1%2.82B+55.7%
$2.64+31.1%$2.01-2.2%$2.06+13.5%$1.81-22.6%$2.34+60.0%
EPS (basic)$2.65+31.1%$2.02-2.2%$2.06+13.6%$1.82-22.6%$2.35+60.0%
Weighted-avg shares (basic)1.12B-2.2%1.14B-1.5%1.16B-1.8%1.18B-1.9%1.20B-2.7%
Weighted-avg shares (diluted)1.12B-2.2%1.14B-1.4%1.16B-1.7%1.18B-1.9%1.20B-2.7%
Dividends per share$1.00+29.5%$0.77+30.8%$0.59-10.4%$0.66-9.5%$0.73+1.8%
Balance Sheetas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Cash & equivalents8.41B+4.5%8.05B+17.9%6.82B-26.5%9.28B+18.2%7.85B-8.7%
Inventory1.70B+11.0%1.53B+1.8%1.50B+18.0%1.27B+11.0%1.15B-10.7%
113B+0.9%112B+4.3%108B-6.4%115B-1.8%117B-4.3%
Operating lease right-of-use1.67B+0.5%1.66B+0.8%1.65B-21.6%2.10B-6.9%2.26B-14.3%
Goodwill4.87B+17.5%4.15B-0.6%4.17B-11.7%4.73B+17.7%4.02B-10.2%
Intangible assets3.63B+3.6%3.50B-0.5%3.52B-9.8%3.90B+17.6%3.32B-13.7%
Short-term & current debt3.61B-1.6%3.67B-3.3%3.79B-1.0%3.83B+6.1%3.61B+30.2%
84.3B-0.4%84.6B+4.2%81.2B-7.6%87.9B-1.8%89.6B-5.2%
Long-term debt37.6B-1.7%38.2B+2.9%37.2B-5.3%39.2B+7.8%36.4B-8.8%
Operating lease liability (total)1.69B+0.6%1.68B+0.7%1.67B-21.2%2.12B-6.5%2.26B-13.6%
Finance lease liability (total)21.4M-57.0%49.9M-4.2%52.0M-3.1%53.7M-15.1%63.3M+105.0%
28.2B+3.6%27.3B+4.7%26.0B-2.4%26.7B-0.4%26.8B-2.0%
Common stock1.39B-5.5%1.47B+0.9%1.46B-12.3%1.67B-8.4%1.82B-9.0%
Additional paid-in capital1.48B-5.1%1.56B+1.3%1.54B-12.2%1.76B-18.0%2.14B-8.6%
Retained earnings22.1B-1.4%22.4B+3.9%21.5B-6.4%23.0B-3.8%23.9B-3.5%
Treasury stock513M+24.7%412M-52.1%859M-6.0%913M-2.1%932M-7.8%
Accumulated other comprehensive income3.81B+67.5%2.28B-3.5%2.36B+100.6%1.18B+991.9%-132M+82.8%
Non-controlling interest571M+4.4%547M+2.8%532M-0.2%533M-41.1%904M+34.0%
Total equity incl. non-controlling28.8B+3.6%27.8B+4.7%26.6B-2.4%27.2B-1.8%27.7B-1.1%
Total liabilities & equity113B+0.9%112B+4.3%108B-6.4%115B-1.8%117B-4.3%
Common shares issued1.12B-3.3%1.16B-4.3%1.21B-1.6%1.23B-1.9%1.26B-2.1%
Common shares outstanding1.10B-3.3%1.14B———
Shares outstanding (cover)1.12B-3.3%1.16B-4.3%1.21B-1.6%1.23B-1.9%1.26B-2.1%
Treasury shares25.5M-4.3%26.7M-58.0%63.5M-1.7%64.5M-0.5%64.9M-5.1%
Cash Flowas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
9.05B+6.2%8.53B-0.8%8.59B+27.4%6.74B-31.3%9.82B-5.6%
Depreciation & amortization2.68B+2.1%2.62B+4.1%2.52B+0.2%2.51B-11.9%2.85B-4.3%
Intangible amortization274M+0.8%271M+0.2%271M+7.2%253M-11.9%287M+5.8%
Deferred income taxes597M+290.3%153M+10.8%138M-49.4%273M+165.7%103M-57.3%
Change in inventory263M+308.0%64.5M-83.9%402M+210.3%129M+106.2%62.8M-44.8%
-7.37B+14.2%-8.59B+9.5%-9.49B-16.9%-8.11B-12.7%-7.20B+36.9%
Capital expenditure496M+9.6%453M-14.5%530M-30.7%765M+94.0%394M-4.9%
Free cash flow8.56B+6.0%8.07B+0.1%8.06B+34.9%5.98B-36.6%9.43B-5.6%
Acquisitions853M+44.7%589M+100.7%294M-80.8%1.53B+96.0%779M+0.6%
Sales/maturities of investments1.07B-36.8%1.69B+416.5%327M-0.6%329M-59.2%805M+168.0%
Proceeds from sale of PP&E2.33B-4.9%2.45B+35.0%1.82B+5.3%1.72B+31.7%1.31B-0.1%
Other investing activities79.6M+148.6%-164M-88.9%-86.7M-748.7%-10.2M+91.3%-118M-179.2%
-1.06B-208.4%979M+265.8%-591M-118.2%3.24B+218.6%-2.73B-825.4%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased992M+182.5%351M+1.6%346M-10.2%385M-13.6%445M-14.9%
Dividends paid1.13B+27.0%889M+28.8%690M-12.1%785M-11.3%885M-1.4%
Other financing activities-63.9M-643.5%-8.59M+6.7%-9.20M+93.0%-132M+13.0%-151M-26.1%
FX effect on cash230M+1214.3%-20.6M-109.0%230M+40.4%164M-24.4%217M+91.6%
Net change in cash853M-4.8%896M+171.4%-1.25B-161.8%2.03B+1765.5%109M+120.7%
Interest paid1.25B+13.1%1.10B-12.7%1.26B+45.1%870M+48.1%587M-22.5%
Income taxes paid758M+2.2%742M+2961.0%24.2M-98.2%1.38B+87.1%739M+2.7%
Valuation Ratiosas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Market cap33.7B+38.8%24.3B-6.7%26.1B+34.3%19.4B-19.4%24.1B+10.4%
P/E11.4×+8.2%10.5×-13.3%12.1×+34.3%9.0×+6.2%8.5×-29.1%
P/S1.5×+18.8%1.3×-2.7%1.3×+34.3%1.0×-8.5%1.1×+6.9%
P/B1.2×+34.0%0.9×-8.7%1.0×+34.3%0.7×-19.0%0.9×+12.6%
P/FCF3.9×+30.9%3.0×-30.9%4.4×+34.3%3.2×+27.1%2.6×+16.9%
Earnings yield8.8%-7.6%9.5%+15.3%8.2%-25.5%11.1%-5.9%11.7%+41.1%
FCF yield25.4%-23.6%33.2%+44.8%22.9%-25.5%30.8%-21.3%39.2%-14.4%
Dividend yield3.3%-9.8%3.7%+38.0%2.7%-33.3%4.0%+10.1%3.7%-13.5%
Source filing20-F20-F20-F20-F20-F

About this data

Source: IX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all IX filings on SEC EDGAR → Not investment advice.